Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ditropan XL and Flomax in LUTS
NCT00338624Phase 3Completed
- Sponsor
- McNeil Laboratories
- Start
- May 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of oxybutynin in lower urinary tract symptoms (LUTS), sponsored by McNeil Laboratories. Started May 2004; status: completed.
02
Drugs
oxybutynin
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT00338624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338624.